A healthy lifestyle will always help with longevity; however, it’s becoming clear that the secret to a long life is largely genetic. But why? This week, we’re bringing you a study that may offer the answer: a gene with a funny-sounding name that’s found in many centenarians. In this edition, you’ll also find data to…
We’ve got a gut feeling that the future of neurology has got a whole lot to do with the microbiome. Recent research has uncovered links between the gut microbiome and the nervous system, and in this edition of NeuroBrief, we learn that those links may teach us something new about multiple sclerosis. Here’s a sneak…
New study upends understanding of the blood–brain barrier. Plus, using imaging to differentiate dementias, and waking the comatose with brain stimulation Since 2012, researchers have used an in vitro model to study the blood–brain barrier. But this week, we bring news of a study that points to a critical flaw in this model that raises…
This week we bring positive research findings—a prostate enlargement drug that may be effective for Parkinson’s disease, another medication’s efficacy in children with relapsing-remitting multiple sclerosis, and a survey indicating that Parkinson’s patients are yearning to learn more about the therapeutic properties of a widely illegal drug. In this edition, you’ll also find new research…
LSD could be on its way from the fringes to the pharmacy. This week, we’re bringing you a new study that has pinpointed the drug’s mechanisms, paving the way for treatment of certain psychiatric disorders. We also have news of how afternoon naps could protect against dementia, a neural network to screen for sleep apnea,…
